Objectives: To determine whether irritable bowel syndrome is associated with impressing history of early infantile colic. Design: A retrospective case controlled study. Setting: Local tertiary hospital in Muhayel Aseer Abha district (Saudi Arabia), Rural area in Abo Hareez, Sharkia Governorate (Egypt) and Al Hussein University Hospital(Cairo, Egypt) from April, 2010 to June, 2012. Participants: Four hundred and fifty cases of irritable bowel syndrome (IBS) that meet the Rome III criteria and one hundred control, aged 7-17 years old. Main outcome Measures: Irritable bowel patients diagnosed on the basis of Rome III criteria for IBS. Complete stool analysis including Helicobacter pylori (H pylori) stool antigen test and occult blood in addition to urea breath test if necessary. Results: Of the total 450 irritable bowel syndrome cases, 195(43.3%) had reported infantile colic at age 0- 4 months compared to 7% in control group, and family history was evident in 179 (91.8%) of combined colic -irritable bowel cases and in 406 (90.2%) irritable bowel cases.H pylori was present in 41.7% of IBS cases compared to 8% in control. Conclusion: Our findings provide a new correlation between childhood irritable bowel syndrome and past history of infantile colic. Moreover, a significant association was found between irritable bowel syndrome and H pylori infection.
[1]
American Society of Colon & Rectal Surgeons, copyright 2014"irritable bowel syndrome R10/12-P01/08.
[2]
Malagelada, JR (2006)."A symptom-based approach to making a positive diagnosis of irritable bowel syndrome with constipation". International journal of clinical practice 60(1): 57–63. doi: 10.1111/j.1368-5031.2005.00744.x.PMID 16409429.
[3]
Cash BD; Schoenfeld P; Chey WD (2002)."The utility of diagnostic tests in irritable bowel syndrome patients: A systematic review. The American journal of gastroenterology 97 (11):2812–9. doi: 10.1111/j.1572-0241.2002.07027.x. PMID 12425553.
[4]
Spiller R, Garsed K (May 2009)."Postinfectious irritable bowel syndrome". Gastroenterology 136 (6):1979–88. doi: 10.1053/j.gastro.2009.02.074.PMID 19457422.
[5]
Chang L (March 2011).The role of stress on physiologic responses and clinical symptoms in irritable bowel syndrome. Gastroenterology 140(3):761–5. doi:10.1053/j.gastro.2011 01.032.PMC 3039211.PMID 21256129.
[6]
Saito YA, Schoenfeld P, Locke GR (August 2002)."The epidemiology of irritable bowel syndrome in North America: a systematic review". Am. J. Gastroenterol. 97(8):1910–5. doi: 10.1111/j.1572-0241.2002.05913.x.PMID 12190153.
[7]
Yawn BP, Lydick E, Locke GR, Wollan PC, Bertram SL, Kurland MJ (2001).Do published guidelines for evaluation of Irritable Bowel Syndrome reflect practice? BMC gastroenterology 1:11. doi: 10.1186/1471-230X-1-11.PMC 59674.
[8]
Mayer EA (April 2008)."Clinical practice. Irritable bowel syndrome". N. Engl. J. Med. 358 (16):1692–9. doi:10.1056 /NEJM cp0801447.PMID 18420501.
[9]
Larry S. Roberts; Gerald Dee Schmidt; John Janovy (2005). Foundations of Parasitology.McGraw-Hill Higher Education. ISBN 978-0-07-111271-0.
[10]
Stark D, van Hal S, Marriott D, Ellis J, Harkness J(2007). "Irritable bowel syndrome: a review on the role of intestinal protozoa and the importance of their detection and diagnosis". Int. J. Parasitol. 37(1):11–20. doi: 10.1016/j.ijpara.2006.09.009. PMID1707081.
[11]
Barbara Bradley Bolen, Ph.D. Irritable bowel syndrome Advice for Parents; Updated September 30,2013.Written or reviewed by a board-certified physician. See About. com's Medical Review Board
[12]
Janet M. Torpy MD, Writer; Robert M. Golub MD, Editor JAMA.2011; 306(13):1501.doi:10.1001/jama.306.13.1501.
[13]
Maxion-Bergemann S, Thielecke F, Abel F, Bergemann R (2006)."Costs of irritable bowel syndrome in the UK and US". Pharmaco Economics 24(1):21–37. doi: 10.2165/00019053-200624010-00002. PMID 16445300.
[14]
Irritable Bowel Syndrome: Criteria for Diagnosis -Topic Overview. (757)668-700 WebMD Medical Reference from Healthwise. Last Updated: April 26, 2012.
[15]
Spiegel BM, DeRosa VP, Gralnek IM, Wang V, Dulai GS(2004). "Testing for celiac sprue in irritable bowel syndrome with predominant diarrhea:a cost-effectiveness analysis". Gastroenterology 126 (7):1721–32. doi: 10.1053/j. gastro.(2004). 03.012.PMID 15188167.
[16]
Su YC, Wang WM, Wang SY et al. (August 2000)."The association between Helicobacter pylori infection and functional dyspepsia in patients with irritable bowel syndrome". Am. J. Gastroenterol.95(8):1900–5. doi: 10.1111 /j 1572-0241.2000.02252.x.PMID 10950033.
[17]
Gerards C, Leodolter A, Glasbrenner B, Malfertheiner P (2001)."H. pylori infection and visceral hypersensitivity in patients with irritable bowel syndrome". Dig Dis 19 (2):170–3. doi:10.1159/000050673. PMID 11549828.
[18]
Grazioli B, Matera G, Laratta C et al. (March 2006)."Giardia lamblia infection in patients with irritable bowel syndrome and dyspepsia: a prospective study".World J. Gastroenterol. 12 (12): 1941–4. PMID 16610003.
[19]
Irritable bowel syndrome. Copyright, 1998-2014 International Foundation for Functional Gastrointestinal Disorders, Inc. (IFFGD).All Rights Reserved. Powered by Net Forge.
[20]
Fass R, Longstreth GF, Pimentel M et al.(2001)."Evidence- and consensus-based practice guidelines for the diagnosis of irritable bowel syndrome". Arch. Intern. Med. 161(17): 2081–8. doi:10.1001/archinte.161.17.2081.PMID 11570936.
[21]
Roberts DM, Ostapchuk O, O, Brien JG. Infantile colic. Am Fam Physician.2004; 70(4):735-740,740-741.
[22]
Abdelrazak M Ali;Helicobacter pylori and infantile colic.in Arch Pediatr Adolesc Med.(2012);166(7):648-650.
[23]
Gulcan EM, Varol A, Kutlu T, et al. Helicobacter pylori stool antigen test. Indian J Pediatr.(2005); 72(8):675-678.
[24]
Sabbi T, De Angelis P, Colistro F, Dall' Oglio L, di Abriola GF, Gastro M. Efficacy of noninvasive tests in the diagnosis of Helicobacter pylori infection in pediatric patients. Arch Pediatr Adolesc Med.(2005); 159(3):238-241.
[25]
Alcon. Lab Inc. USA. San Diego, CA 92121 (2005) No: 1150
[26]
Kato S, Ozawa K, Konno M. et al. Diagnostic accuracy of the 13C –urea breath test of childhood Helicobacter pylori infection; Multicenter Japanese study, Am. J. Gastro enterol. (2000); 95; 646 650.
[27]
Nicholas JI, Alan RZ and Melton LJ. Prevelance of irritable bowel syndrome in community: symptoms, subgroups, risk factors and health care utilization. Am J of Epidem vol 142, issue 11 pp,76-83. .
[28]
Caroline Canavan, Joe West, and Timothy Card.The epidemiology of irritable bowel syndrome. Clin Epidemiol.(2014); 6:71–80.Published online Feb, 4, 2014.doi: 10.2147/CLEP. S40245 .PMCID:PMC39210
[29]
Abdelrazak MA .Helicobacter pylori and infantile colic. Arch Pediatr Adolesc Med.2012; 166(7):648-650.31.
[30]
Abdelrazak MA, Samir MZ. Infantile colic: Is there there an association with the source of early infant nutrition? Zagazig Univ Med J.2002;8(7):1233-1242.
[31]
j Yakoob ,z Abbas, M Islam et al"Virulence markers of Helicobacter pylori in patients with diarrhoea-dominant irritable bowel syndrome (2012)Br J Biomed Sci ; 69(1); 6-10, Copyright ©2014 Institute of Biomedical Science.
[32]
Hungin A.P.S, Whorwell P J., Tack J and. Mearin F .The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40 000 subjects. Alimentary Pharmacology &Therapeutics Volume 17, Issue 5, pages 643–650, March, 2003.
[33]
K. KAJANDER E. MYLLYLUOMA, M. RAJILIĆ-STOJANOVIĆ, et al. Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota. Alimentary Pharmacology & Therapeutics. Volume 27, Issue 1, pp, 48-57 , January 2008. Article first published online: 6 OCT 2007DOI: 10.1111/j.1365-2036.2007.0
[34]
35. Jolanta Sarowska, Irena Choroszy-Krol, Bożena Regulska-Ilow et al.The Therapeutic Effect of Probiotic Bacteria on Gastrointestinal Diseases 'Adv Clin Exp Med 2013, 22, 5, 759–766, ISSN 1899–5276.
[35]
Liam O’Mahony*,Jane McCarthy*,Peter Kelly*,George Hurley, et al. Lactobacillus and bifidobacterium in irritable bowel syndrome: Symptom responses and relationship to cytokine profiles Gastroenterology.Volume 128, Issue 3, March (2005), Pages 541–551.
[36]
Smits HH, Engering A, van der Kleij D et al. Selective probiotic bacteria induce IL-10 producing regulatory Tcells in vitro by modulating dendritic cell function through denderitic cell -specific intracellular adhesion molecule 3-grabbing nonintegrin. J Allergy Clinical Immunol. (2005); 115(6):1260-1267.
[37]
Valeeur N, Engel P, Carbajal N, Connoly E, Ladefoged K. Colonization and immunomodulation by Lactobacillus reuteri ATCC 55730 in the human gastrointestinal tract. Appl Environ Microbiol .(2004);70(2):1176-1181..
[38]
Madaliński K, Szajewska H: Probiotics:mechanism of action, immunomodulation and potential use in gastrointestinal diseases. Zakażenia(2004);5,42–48.
[39]
Czerwionka-Szaflarska M, Romańczuk B: Probiotics – which, whom, when? Przew Lek( 2008),1, 214–221.
[40]
Posserud I, Stotzer PO, Björnsson ES, Abrahamsson H, Simrén M (2007)."Small intestinal bacterial overgrowth in patients with irritable bowel syndrome".Gut 56 (6): 802–8. doi:10.1136/gut.2006.108712. PMC 1954873.PMID 17148502.
[41]
Yakoob J, Jafri W, Jafri N et al. (2004)."Irritable bowel syndrome: in search of an etiology: role of Blastocystis hominis". Am. J. Trop. Med. Hyg. 70(4): 383–5.PMID 15100450.
[42]
Giacometti A, Cirioni O, Fiorentini A, Fortuna M, Scalise G (1999)."Irritable bowel syndrome in patients with Blastocystis hominis infection". Eur. J. Clin. Microbiol. Infect. Dis.18 (6): 436–9. doi: 10.1007/s100960050314.PMID 10442423.Windsor JJ, Macfarlane L (May 2005).
[43]
"Irritable bowel syndrome: the need to exclude Dientamoeba fragilis". Am. J. Trop. Med. Hyg. 72 (5): 501; author reply 501–2.PMID 15891119. Retrieved November 4, 2009.
